Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds
MAY 31, 2019
8:00am - 6:00pm
FDA White Oak Campus Building 31, Room 1503 - Great Room 10903 New Hampshire Ave Silver Spring, MD 20993
ABOUT
Cannabis is a plant of the Cannabaceae family and contains more than 80 biologically active chemical compounds. The most commonly known compounds are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Parts of the Cannabis sativa plant have been controlled under the Federal Controlled Substances Act (CSA) since 1970 under the drug class “Marihuana” (21 U.S.C. 802(16).[1] “Marihuana” is listed in Schedule I of the CSA due to its high potential for abuse, which is attributable in large part to the psychoactive effects of THC, and the absence of a currently accepted medical use for marijuana in the United States. Cannabis and cannabis-derived products have been the subject of increasing interest by consumers, industry, researchers, the public, and regulators. Regulatory oversight of products containing cannabis or cannabis-derived compounds is complex and involves multiple Federal and State agencies. The goal of the hearing is to obtain additional scientific data and other information related to cannabis and cannabis-derived compounds, both from botanical and synthetic sources, to inform our regulatory oversight of these products. This hearing is particularly important in light of the passage of the Agriculture Improvement Act of 2018, Public Law 115-334 (the 2018 Farm Bill), which, among other things removed the plant Cannabis sativa L. or “hemp” from the Controlled Substances Act. While the Farm Bill is intended to facilitate the production and marketing of hemp, it explicitly preserved FDA's authority to regulate hemp products. FDA does not intend for this hearing to produce any decisions or new positions on specific regulatory questions, but this hearing is expected to be an important step in our continued evaluation of all cannabis and cannabis-derived compounds in FDA-regulated products, including products containing hemp. As stated in the Federal Register notice, requests to attend the hearing in person and/or to make a presentation/provide oral comments during the hearing must be received by May 10th. Due to space and time limitations, it is possible that not all can be accommodated. Therefore, registering on this site does not guarantee in person attendance and/or a time slot to make a presentation/provide oral comments. Your confirmation to attend the hearing in person and/or to make a presentation/provide oral comments will be provided by May 21, 2019. Registrants can also view the hearing via webcast. All meeting attendees and other interested parties may submit information to the public docket FDA-2019-N-1482. For more information about the meeting, as well as how to submit written comments afterwards, see the FDA Event Page. For general questions about the meeting or to request special accommodations due to a disability, contact Beth F. Fritsch, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 5308, Silver Spring, MD 20993, phone: 301-796-8451, email: StakeholderEngagement@fda.hhs.gov
REGISTRATION
DIRECTIONS
The public hearing will be held at FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993. Entrance for the public hearing participants (non-FDA employees) is through Building 1, where routine security check procedures will be performed. A visitor badge and escort will not be required to attend a public meeting in the Great Room. For driving directions and parking information: please refer to FDA White Oak Campus Information
LODGING
Below is a list of properties convenient to the FDA facility in Silver Spring, MD. The sleeping room rate and availability at each property cannot be guaranteed and guests should contact the properties directly for more information.
Lodging Near the White Oak Conference Center
Hotels located within six miles of the White Oak Conference Center:
College Park North Hotel
4095 Powder Mill Road Beltsville, MD 20705 301-937-4422 (4 miles)
College Park Marriott Hotel & Conference Center
3501 University Boulevard East Hyattsville, MD 20783 301-985-7300 https://www.marriott.com/wasum (4.1 miles)
Comfort Inn College Park North
4050 Powder Mill Road Beltsville, MD 20705 520-979-3852 (6.2 miles)
Courtyard by Marriott Silver Spring Downtown
8506 Fenton Street Silver Spring, MD 20910 301-589-4899 (4.4 miles)
Courtyard by Marriott Silver Spring North – White Oak
12521 Prosperity Drive Silver Spring, MD 20904 301-680-8500 https://www.marriott.com/wasss (2.9 miles)
Double Tree by Hilton Washington, DC – Silver Spring
8727 Colesville Road Silver Spring, MD 20910 301-589-5200 (4.1 miles)
Hampton Inn College Park
9670 Baltimore Avenue College Park, MD 20740 301-345-2200 (4.4 miles)
Hampton Inn Silver Spring
8728-A Colesville Road Silver Spring, MD 20910 301-588-5887 (4.2 miles)
Hilton Garden Inn Silver Spring North
2200 Broadbirch Drive Silver Spring, MD 20904 301-622-3333 (2.5 miles)
Holiday Inn Express & Suites College Park – University Area
9020 Baltimore Avenue College Park, MD 20740 301-441-8110 (5.3 miles)
Holiday Inn Washington – College Park (I-95)
10000 Baltimore Avenue College Park, MD 20740 301-345-6700 (4.8 miles)
Home2 Suites by Hilton Silver Spring
1701 Elton Road Silver Spring, Maryland 20903 301-965-8200 http://home2silverspring.home2suitesbyhilton.com (1 mile)
Homewood Suites by Hilton Silver Spring
8728 Colesville Road Silver Spring, MD 20910 301-565-0005 (4.2 miles)
Residence Inn by Marriott Silver Spring
12000 Plum Orchard Drive Silver Spring, MD 20904 301-572-2322 https://www.marriott.com/waslv (3.7 miles)
Sheraton Silver Spring Hotel
8777 Georgia Avenue Silver Spring, MD 20910 http://www.sheratonsilverspring.com 301-589-0800 (4.6 miles)